Jeffrey R Marks

Title: The Innovations of Jeffrey R Marks

Introduction

Jeffrey R Marks is a notable inventor based in Hillsborough, NC (US), recognized for his contributions to the field of pharmaceuticals and genetics. With a total of three patents to his name, Marks has made significant strides in developing methods that enhance the understanding of drug metabolism and gene expression.

Latest Patents

Marks' latest patents include innovative methods for evaluating the ability to metabolize pharmaceuticals. These methods focus on detecting variant genes associated with reduced metabolism of specific substrates, such as CYP3A4 and CYP3A5. The genotyping methods he developed identify polymorphisms linked to the metabolism of chemotherapeutic agents, including cyclophosphamide and BCNU. Additionally, he has patented antisense oligonucleotides against the ERBB-2 tyrosine kinase receptor, which are useful for inhibiting its expression in various cellular contexts.

Career Highlights

Throughout his career, Jeffrey R Marks has worked with prestigious institutions, including Duke University and Genaissance Pharmaceuticals, Inc. His work has significantly impacted the pharmaceutical industry, particularly in the areas of drug metabolism and genetic research.

Collaborations

Marks has collaborated with notable individuals in his field, including James Dirk Inglehart and Andrew Mark Davidoff. These collaborations have furthered his research and contributed to the advancement of innovative solutions in pharmaceuticals.

Conclusion

Jeffrey R Marks stands out as an influential inventor whose work in pharmaceuticals and genetics continues to shape the industry. His patents reflect a commitment to improving drug metabolism understanding and developing targeted therapies.